Value of the critical flicker frequency in patients with minimal hepatic encephalopathy

Minimal hepatic encephalopathy (MHE) is mainly diagnosed using psychometric tests such as the psychometric hepatic encephalopathy score (PHES). Despite the clinical and social relevance of MHE, psychometric testing is not widespread in routine clinical care. We assessed the usefulness of the critical flicker frequency (CFF), for the diagnosis of MHE and for the prediction of the development of overt episodes of HE. The normal range of PHES in the Spanish population was evaluated in a control group. Subsequently, 114 patients with cirrhosis and 103 healthy controls underwent both PHES and CFF tests. A diagnosis of MHE was made when the PHES was lower than −4 points. Patients were followed‐up every 6 months for a total of 1 year. CFF did not correlate with age, education, or sex in the control group. The mean CFF was significantly lower in patients with MHE versus non‐MHE or controls. Mean CFF correlated with individual psychometric tests as well as PHES (r = 0.54; P < 0.001). CFF <38 Hz was predictive of further bouts of overt HE (log‐rank: 14.2; P < 0.001). There was a weak correlation between mean CFF and Child‐Pugh score but not with model for end‐stage liver disease score. In multivariate analysis using Cox regression, CFF together with Child‐Pugh score was independently associated with the development of overt HE. Conclusion: CFF is a simple, reliable, and accurate method for the diagnosis of MHE. It is not influenced by age or education and could predict the development of overt HE. (HEPATOLOGY 2007;45:879–885.)

[1]  W. Hop,et al.  The prognostic significance of subclinical hepatic encephalopathy. , 2000 .

[2]  K. Weissenborn,et al.  Attention Deficits in Minimal Hepatic Encephalopathy , 2001, Metabolic Brain Disease.

[3]  J. Schölmerich,et al.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis , 1996, Hepatology.

[4]  A. Lockwood,et al.  Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998 , 2002, Hepatology.

[5]  C. Wein,et al.  Minimal hepatic encephalopathy impairs fitness to drive , 2004, Hepatology.

[6]  Lars Timmermann,et al.  Critical flicker frequency for quantification of low‐grade hepatic encephalopathy , 2002, Hepatology.

[7]  J. Wattis,et al.  Critical flicker fusion threshold: a potentially useful measure for the early detection of Alzheimer's disease , 2000, Human psychopharmacology.

[8]  Manuel Romero-Gómez,et al.  Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy , 2001, American Journal of Gastroenterology.

[9]  K Weissenborn,et al.  Neuropsychological characterization of hepatic encephalopathy. , 2001, Journal of hepatology.

[10]  J. Inadomi,et al.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. , 2000, Journal of hepatology.

[11]  R. de Franchis Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. , 2000, Journal of hepatology.

[12]  M. Romero-Gómez,et al.  Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy , 2004, Hepatology.

[13]  F. Chan,et al.  Survival and Prognostic Indicators in Patients with Hepatitis B Virus–Related Cirrhosis After Onset of Hepatic Decompensation , 2002, Journal of clinical gastroenterology.

[14]  R. Jover,et al.  Clinical significance of extrapyramidal signs in patients with cirrhosis. , 2003, Journal of hepatology.

[15]  M. Vergara-Gómez,et al.  [Diagnosis and treatment of hepatic encephalopathy in Spain: results of a survey of hepatologists]. , 2006, Gastroenterologia y hepatologia.

[16]  C. McClain,et al.  Psychomotor performance defects in cirrhotic patients without overt encephalopathy. , 1980, Archives of internal medicine.

[17]  R. Dhiman,et al.  Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis , 2001, Journal of gastroenterology and hepatology.

[18]  Suzanne Corkin,et al.  Visual dysfunction in Alzheimer's disease: Relation to normal aging , 1991, Annals of neurology.

[19]  A. Fernández,et al.  Tablas de normalidad de la población española para los tests psicométricos utilizados en el diagnóstico de la encefalopatía hepática mínima , 2006 .

[20]  M. Morgan,et al.  Methods for Diagnosing Hepatic Encephalopathy in Patients with Cirrhosis: A Multidimensional Approach , 2004, Metabolic Brain Disease.

[21]  N. Gitlin,et al.  The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. , 1986, Journal of hepatology.

[22]  R J Mason,et al.  Abnormalities of chromatic and luminance critical flicker frequency in multiple sclerosis. , 1982, Investigative ophthalmology & visual science.

[23]  M. Navasa,et al.  Prognostic significance of hepatic encephalopathy in patients with cirrhosis. , 1999, Journal of hepatology.

[24]  W. Hop,et al.  Subclinical hepatic encephalopathy impairs daily functioning , 1998, Hepatology.

[25]  P. Angeli,et al.  Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. , 2001, Journal of hepatology.

[26]  M. Vergara-Gómez,et al.  Diagnóstico y tratamiento de la encefalopatía hepática en España: resultados de una encuesta dirigida a hepatólogos , 2006 .